Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies. (terbuka di window baru)

Antun AG, Gleason S, Arellano M, Langston AA, McLemore ML, Gaddh M, el Rassi F, Bernal-Mizrachi L, Galipeau J, Heffner LT Jr, Winton EF, Khoury HJ.

Sumber‎: Cancer 2013;119(21):3784-7.

Index‎: PubMed 23921838

DOI‎: 10.1002/cncr.28253

https://www.ncbi.nlm.nih.gov/pubmed/23921838 (terbuka di window baru)

Tranexamic acid for control of haemorrhage in acute promyelocytic leukaemia. (terbuka di window baru)

Avvisati G, ten Cate JW, Büller HR, Mandelli F.

Sumber‎: Lancet 1989;334(8655):122-4.

Index‎: PubMed 2567893

https://www.ncbi.nlm.nih.gov/pubmed/2567893 (terbuka di window baru)

Tranexamic acid therapy in acute myeloid leukemia: possible reduction of platelet transfusions. (terbuka di window baru)

Ben-Bassat I, Douer D, Ramot B.

Sumber‎: Eur J Haematol 1990;45(2):86-9.

Index‎: PubMed 2209824

https://www.ncbi.nlm.nih.gov/pubmed/2209824 (terbuka di window baru)

Fibrinolytic inhibitors for cancer-associated bleeding problems. (terbuka di window baru)

Dean A, Tuffin P.

Sumber‎: J Pain Symptom Manage 1997;13(1):20-4.

Index‎: PubMed 9029858

https://www.ncbi.nlm.nih.gov/pubmed/9029858 (terbuka di window baru)

Autologous stem-cell transplantation without hematopoietic support for the treatment of hematologic malignancies in Jehovah's Witnesses. (terbuka di window baru)

Ford PA, Grant SJ, Mick R, Keck G.

Sumber‎: J Clin Oncol 2015;33(15):1674-9.

Index‎: PubMed 25870085

DOI‎: 10.1200/JCO.2014.57.9912

https://www.ncbi.nlm.nih.gov/pubmed/25870085 (terbuka di window baru)

Anti-fibrinolytic therapy with aminocaproic acid for the control of bleeding in thrombocytopenic patients. (terbuka di window baru)

Garewal HS, Durie BG.

Sumber‎: Scand J Haematol 1985;35(5):497-500.

Index‎: PubMed 4089529

https://www.ncbi.nlm.nih.gov/pubmed/4089529 (terbuka di window baru)

Epsilon aminocaproic acid reduces transfusion requirements in patients with thrombocytopenic hemorrhage. (terbuka di window baru)

Kalmadi S, Tiu R, Lowe C, Jin T, Kalaycio M.

Sumber‎: Cancer 2006;107(1):136-40.

Index‎: PubMed 16708357

DOI‎: 10.1002/cncr.21958

https://www.ncbi.nlm.nih.gov/pubmed/16708357 (terbuka di window baru)

Aminocaproic acid use in hospitalized patients with hematological malignancy: a case series. (terbuka di window baru)

Marshall A, Li A, Drucker A, Dzik W.

Sumber‎: Hematol Oncol 2016;34(3):147-53.

Index‎: PubMed 25641349

DOI‎: 10.1002/hon.2189

https://www.ncbi.nlm.nih.gov/pubmed/25641349 (terbuka di window baru)

Tranexamic acid to treat life-threatening hemorrhage in prostate cancer associated disseminated intravascular coagulation with excessive fibrinolysis. (terbuka di window baru)

Prokopchuk-Gauk O, Brose K.

Sumber‎: Cureus 2015;7(12):e428.

Index‎: PubMed 26848417

DOI‎: 10.7759/cureus.428

https://www.ncbi.nlm.nih.gov/pubmed/26848417 (terbuka di window baru)

A controlled trial of tranexamic acid therapy for the reduction of bleeding during treatment of acute myeloid leukemia. (terbuka di window baru)

Shpilberg O, Blumenthal R, Sofer O, Katz Y, Chetrit A, Ramot B, Eldor A, Ben-Bassat I.

Sumber‎: Leuk Lymphoma 1995;19(1-2):141-4.

Index‎: PubMed 8574160

DOI‎: 10.3109/10428199509059668

https://www.ncbi.nlm.nih.gov/pubmed/8574160 (terbuka di window baru)

Acute promyelocytic leukaemia and acquired alpha-2-plasmin inhibitor deficiency: a retrospective look at the use of epsilon-aminocaproic acid (Amicar) in 30 patients. (terbuka di window baru)

Wassenaar T, Black J, Kahl B, Schwartz B, Longo W, Mosher D, Williams E.

Sumber‎: Hematol Oncol 2008;26(4):241-6.

Index‎: PubMed 18613223

DOI‎: 10.1002/hon.867

https://www.ncbi.nlm.nih.gov/pubmed/18613223 (terbuka di window baru)

Use of Novoseven for arsenic trioxide-induced bleeding in PML. (terbuka di window baru)

Alimoghaddam K, Ghavamzadeh A, Jahani M.

Sumber‎: Am J Hematol 2006;81(9):720.

Index‎: PubMed 16804937

DOI‎: 10.1002/ajh.20713

https://www.ncbi.nlm.nih.gov/pubmed/16804937 (terbuka di window baru)

Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: an audit of the clinical use of recombinant activated Factor VII. (terbuka di window baru)

Brenner B, Hoffman R, Balashov D, Shutluko E, Čulić SD, Nizamoutdinova E.

Sumber‎: Clin Appl Thromb Hemost 2005;11(4):401-10.

Index‎: PubMed 16244765

https://www.ncbi.nlm.nih.gov/pubmed/16244765 (terbuka di window baru)

The off-label use of recombinant FVIIa in the treatment of a patient with T-cell non-Hodgkin lymphoma who developed intra-abdominal and intra-pleural hemorrhages followed by high-dose methotreaxate therapy. (terbuka di window baru)

Erduran E, Bahadir A, Mutlu M.

Sumber‎: Eur J Clin Med Oncol 2011;3(5):1-4.

Index‎: EMBASE 2012295551

https://www.worldcat.org/title/european-journal-of-clinical-medical-oncology/oclc/645421559&referer=brief_results (terbuka di window baru)

The potential role of recombinant activated FVII in the management of critical hemato-oncological bleeding: a systematic review. (terbuka di window baru)

Franchini M, Veneri D, Lippi G.

Sumber‎: Bone Marrow Transplant 2007;39(12):729-35.

Index‎: PubMed 17417659

DOI‎: 10.1038/sj.bmt.1705670

https://www.ncbi.nlm.nih.gov/pubmed/17417659 (terbuka di window baru)

Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage. (terbuka di window baru)

Gerotziafas GT, Zervas C, Gavrielidis G, Tokmaktsis A, Hatjiharissi E, Papaioannou M, Lazaridou A, Constantinou N, Samama MM, Christakis J.

Sumber‎: Am J Hematol 2002;69(3):219-22.

Index‎: PubMed 11891811

https://www.ncbi.nlm.nih.gov/pubmed/11891811 (terbuka di window baru)

Use of recombinant activated factor VII in a Jehovah's Witness patient. (terbuka di window baru)

Hsieh A, Cheong I.

Sumber‎: Am J Emerg Med 2007;25(9):1085.e1-2.

Index‎: PubMed 18022514

DOI‎: 10.1016/j.ajem.2007.03.007

https://www.ncbi.nlm.nih.gov/pubmed/18022514 (terbuka di window baru)

Clinical experience with recombinant factor VIIa in patients with thrombocytopenia. (terbuka di window baru)

Kristensen J, Killander A, Hippe E, Helleberg C, Ellegard J, Holm M, Kutti J, Mellqvist UH, Johansson JE, Glazer S, Hedner U.

Sumber‎: Haemostasis 1996;26 Suppl 1:159-64.

Index‎: PubMed 8904193

https://www.ncbi.nlm.nih.gov/pubmed/8904193 (terbuka di window baru)

Successful treatment of severe gastrointestinal bleeding after chemotherapy in acute myeloblastic leukemia with recombinant activated factor VII: report on one case and review of other uses in acute leukemias. (terbuka di window baru)

Pamuk GE, Taşçi M, Oztürk E, Demir M.

Sumber‎: Med Oncol 2010;27(1):16-9.

Index‎: PubMed 19137431

DOI‎: 10.1007/s12032-008-9163-y

https://www.ncbi.nlm.nih.gov/pubmed/19137431 (terbuka di window baru)

Recombinant factor VIIa for bleeding in refractory thrombocytopenia. (terbuka di window baru)

Vidarsson B, Önundarson PT.

Sumber‎: Thromb Haemost 2000;83(4):634-5.

Index‎: PubMed 10780334

https://www.ncbi.nlm.nih.gov/pubmed/10780334 (terbuka di window baru)

Effective treatment of life-threatening bleeding with recombinant activated factor VII in a patient with acute promyelocytic leukaemia. (terbuka di window baru)

Zver S, Andoljšek D, Černelč P.

Sumber‎: Eur J Haematol 2004;72(6):455-6.

Index‎: PubMed 15128428

DOI‎: 10.1111/j.1600-0609.2004.00237.x

https://www.ncbi.nlm.nih.gov/pubmed/15128428 (terbuka di window baru)

Management of bleeding complications of hematologic malignancies. (terbuka di window baru)

Green D.

Sumber‎: Semin Thromb Hemost 2007;33(4):427-34.

Index‎: PubMed 17525900

DOI‎: 10.1055/s-2007-976178

https://www.ncbi.nlm.nih.gov/pubmed/17525900 (terbuka di window baru)

Vitamin K deficiency in cancer patients referred to a hospital palliative care team with bleeding and the impact of vitamin K replacement on laboratory indicators of vitamin K status. (terbuka di window baru)

Harrington DJ, Booth L, Dando N, Cottingham L, Beynon T.

Sumber‎: Int J Lab Hematol 2013;35(4):457-9.

Index‎: PubMed 23216984

DOI‎: 10.1111/ijlh.12035

https://www.ncbi.nlm.nih.gov/pubmed/23216984 (terbuka di window baru)

Management of bleeding in patients with advanced cancer. (terbuka di window baru)

Pereira J, Phan T.

Sumber‎: Oncologist 2004;9(5):561-70.

Index‎: PubMed 15477642

DOI‎: 10.1634/theoncologist.9-5-561

https://www.ncbi.nlm.nih.gov/pubmed/15477642 (terbuka di window baru)

Pilot study on the safety and efficacy of desmopressin for the treatment or prevention of bleeding in patients with hematologic malignancies. (terbuka di window baru)

Castaman G, Bona ED, Schiavotto C, Trentin L, D'Emilio A, Rodeghiero F.

Sumber‎: Haematologica 1997;82(5):584-7.

Index‎: PubMed 9407726

https://www.ncbi.nlm.nih.gov/pubmed/9407726 (terbuka di window baru)

Desmopressin and other synthetic vasopressin analogues in cancer treatment. (terbuka di window baru)

Gomez DE, Ripoll GV, Girón S, Alonso DF.

Sumber‎: Bull Cancer 2006;93(2):E7-12.

Index‎: PubMed 16517412

https://www.ncbi.nlm.nih.gov/pubmed/16517412 (terbuka di window baru)